Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Divestments: 2019-2024

Historic Divestments for Agios Pharmaceuticals (AGIO) over the last 4 years, with Dec 2024 value amounting to $200.0 million.

  • Agios Pharmaceuticals' Divestments rose 696214.29% to $1.8 billion in Q1 2021 from the same period last year, while for Mar 2021 it was $1.8 billion, marking a year-over-year change of. This contributed to the annual value of $200.0 million for FY2024, which is N/A change from last year.
  • As of FY2024, Agios Pharmaceuticals' Divestments stood at $200.0 million, which was down 88.91% from $1.8 billion recorded in FY2021.
  • In the past 5 years, Agios Pharmaceuticals' Divestments registered a high of $1.8 billion during FY2021, and its lowest value of -$803,000 during FY2020.
  • For the 1-year period, Agios Pharmaceuticals' Divestments averaged around $200.0 million, with its median value being $200.0 million (2024).
  • Per our database at Business Quant, Agios Pharmaceuticals' Divestments tumbled by 461.54% in 2020 and then skyrocketed by 224,625.03% in 2021.
  • Over the past 3 years, Agios Pharmaceuticals' Divestments (Yearly) stood at -$803,000 in 2020, then spiked by 224,625.03% to $1.8 billion in 2021, then reached $200.0 million in 2024.